AuraVax licenses intranasal vaccine platform October 12, 2020 -- Vaccine biotechnology firm AuraVax Therapeutics has entered into an exclusive licensing option agreement with the University of Houston for a unique intranasal vaccine technology.
Oncopeptides moves to file for regulatory approvals October 12, 2020 -- Oncopeptides plans to submit an application for a conditional marketing authorization of melflufen in the European Union, based on the phase II Horizon study in relapsed refractory multiple myeloma.
Grifols begins trial for SARS-CoV-2 hyperimmune globulin October 9, 2020 -- Grifols has started its anti-SARS-CoV-2 hyperimmune globulin clinical trial, named Inpatient Treatment with Anti-Coronavirus Immunoglobulin. The hyperimmune globulin provides a high and consistent concentration of purified neutralizing antibodies that could be used for both prevention and treatment of COVID-19.
J&J to supply EU with 200M COVID-19 vaccine doses October 8, 2020 -- Johnson & Johnson has received approval from the European Commission to supply 200 million doses of Janssen Pharmaceutical's COVID-19 vaccine candidate to European Union (EU) member states following approval from regulators.
NCI launches SeroNet October 8, 2020 -- The U.S. National Cancer Institute (NCI) launched its Serological Sciences Network for COVID-19 (SeroNet) on October 8.